| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study
|
Wettergren, Yvonne
|
|
2014
|
75 |
1 |
p. 37-47
|
article
|
| 2 |
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
|
Sharma, Sunil
|
|
2014
|
75 |
1 |
p. 87-95
|
article
|
| 3 |
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor
|
Koo, Dong-Hoe
|
|
2014
|
75 |
1 |
p. 173-182
|
article
|
| 4 |
Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury
|
Nojiri, Takashi
|
|
2014
|
75 |
1 |
p. 123-129
|
article
|
| 5 |
Biological evaluation of a novel sorafenib analogue, t-CUPM
|
Wecksler, Aaron T.
|
|
2014
|
75 |
1 |
p. 161-171
|
article
|
| 6 |
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death
|
Singh, Simendra
|
|
2014
|
75 |
1 |
p. 1-15
|
article
|
| 7 |
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections
|
Wright, Karen D.
|
|
2014
|
75 |
1 |
p. 27-35
|
article
|
| 8 |
Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer
|
Kontopodis, E.
|
|
2014
|
75 |
1 |
p. 153-160
|
article
|
| 9 |
Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer
|
Haroun, F.
|
|
2014
|
75 |
1 |
p. 207-214
|
article
|
| 10 |
EGFR–TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation
|
Koo, Dong-Hoe
|
|
2014
|
75 |
1 |
p. 197-206
|
article
|
| 11 |
Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer
|
Hochster, H. S.
|
|
2014
|
75 |
1 |
p. 25
|
article
|
| 12 |
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
|
Levinsen, Mette
|
|
2014
|
75 |
1 |
p. 59-66
|
article
|
| 13 |
Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing
|
Inoue, Kouichi
|
|
2014
|
75 |
1 |
p. 49-58
|
article
|
| 14 |
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer
|
Hochster, H. S.
|
|
2014
|
75 |
1 |
p. 17-23
|
article
|
| 15 |
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
|
Tolcher, Anthony W.
|
|
2014
|
75 |
1 |
p. 183-189
|
article
|
| 16 |
Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer
|
Uwagawa, Tadashi
|
|
2014
|
75 |
1 |
p. 191-196
|
article
|
| 17 |
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews
|
Eiseman, Julie L.
|
|
2014
|
75 |
1 |
p. 143-152
|
article
|
| 18 |
Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration
|
McCune, Jeannine S.
|
|
2014
|
75 |
1 |
p. 67-75
|
article
|
| 19 |
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies
|
Marostica, Eleonora
|
|
2014
|
75 |
1 |
p. 111-121
|
article
|
| 20 |
Population pharmacokinetics of HM781-36 (poziotinib), pan-human EGF receptor (HER) inhibitor, and its two metabolites in patients with advanced solid malignancies
|
Noh, Yook-Hwan
|
|
2014
|
75 |
1 |
p. 97-109
|
article
|
| 21 |
Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery
|
Lim, Hyun-ju
|
|
2014
|
75 |
1 |
p. 77-85
|
article
|
| 22 |
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors
|
Edeline, Julien
|
|
2014
|
75 |
1 |
p. 215-219
|
article
|
| 23 |
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts
|
Croucher, Jamie L.
|
|
2014
|
75 |
1 |
p. 131-141
|
article
|
Journal description